Article Details

Roche Builds Case For Evrysdi Benefits In Younger Spinal Muscular Atrophy Patients - Benzinga

Retrieved on: 2021-09-24 17:26:15

Tags for this article:

Click the tags to see associated articles and topics

Roche Builds Case For Evrysdi Benefits In Younger Spinal Muscular Atrophy Patients - Benzinga. View article details on HISWAI: https://www.benzinga.com/general/biotech/21/09/23094393/roche-builds-case-for-evrysdi-benefits-in-younger-spinal-muscular-atrophy-patients

Excerpt

The new data "may help extend the potential benefits of this medicine to the youngest SMA patients," according to Roche's chief medical officer Levi Garraway.

Article found on: www.benzinga.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up